ESTRO 2024 - Abstract Book

S414

Brachytherapy - Urology

ESTRO 2024

We show that high-risk PCa patients classified according to the 3-tier NCCN system benefit from further stratification using the CAPRA score or the 5- tier NCCN stratification method. Patients with a CAPRA score ≥6 and those classified as very-high risk by the NCCN had a higher risk of BCR, metastasis, and death. This subset of patients might benefit from further intensifying their investigations and treatment, underscoring the importance of ongoing research. Given the comparable performances of both predictive tools, the choice between them may rely on personal or institutional preferences.

Keywords: Risk factors, stratification, prognosis

References:

[1] Brenner DR, Poirier A, Woods RR, Ellison LF, Billette J-M, Demers AA, et al. Projected estimates of cancer in Canada in 2022. Can Med Assoc J 2022;194:E601 – 7. https://doi.org/10.1503/cmaj.212097.

[2] Tolkach Y, Kristiansen G. The Heterogeneity of Prostate Cancer: A Practical Approach. Pathobiology 2018;85. https://doi.org/10.1159/000477852.

[3] Clinckaert A, Devos G, Roussel E, Joniau S. Risk stratification tools in prostate cancer, where do we stand? Transl Androl Urol 2021;10. https://doi.org/10.21037/TAU-20-1211.

[4] Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al. NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023. J Natl Compr Canc Netw 2022;20:1288 – 98. https://doi.org/10.6004/jnccn.2022.0063.

[5] Zelic R, Garmo H, Zugna D, Stattin P, Richiardi L, Akre O, et al. Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study. Eur Urol 2020;77. https://doi.org/10.1016/j.eururo.2019.09.027.

[6] Hernandez DJ, Nielsen ME, Han M, Partin AW. Contemporary Evaluation of the D’Amico Risk Classification of Prostate Cancer. Urology 2007;70. https://doi.org/10.1016/j.urology.2007.08.055.

[7] Reese AC, Pierorazio PM, Han M, Partin AW. Contemporary evaluation of the national comprehensive cancer network prostate cancer risk classification system. Urology 2012;80. https://doi.org/10.1016/j.urology.2012.07.040.

[8] Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Duchane J, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. Journal of Urology 2005;173. https://doi.org/10.1097/01.ju.0000158155.33890.e7.

1457

Digital Poster

Focal hyaluronic acid spacer injection before focal brachytherapy for local pelvic recurrence